Studies have shown that COL8A1 promotes triple‐negative breast cancer growth through FAK/Src signalling pathway activation [11] and facilitates NSCLC progression by influencing EGFR activation, mediated by IFIT1/IFIT3 [12]. This evidence concerns the gene COL8A1 and non-small cell lung carcinoma.